Suppr超能文献

多种抑制剂对蛋白激酶Cμ的抑制作用。与蛋白激酶C同工酶的区别。

Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase c isoenzymes.

作者信息

Gschwendt M, Dieterich S, Rennecke J, Kittstein W, Mueller H J, Johannes F J

机构信息

German Cancer Research Center, Heidelberg, Germany.

出版信息

FEBS Lett. 1996 Aug 26;392(2):77-80. doi: 10.1016/0014-5793(96)00785-5.

Abstract

Various inhibitors were tested for their potential to suppress the kinase activity of protein kinase C mu (PKC mu) in vitro and in vivo. Among the staurosporine-derived, rather selective PKC inhibitors the indolocarbazole Gö 6976 previously shown to inhibit preferentially cPKC isotypes proved to be a potent inhibitor of PKC mu with an IC50 of 20 nM, whereas the bisindolylmaleimide Gö 6983 was extremely ineffective in suppressing PKC mu kinase activity with a thousand-fold higher IC50 of 20 microM. Other strong inhibitors of PKC mu were the rather unspecific inhibitors staurosporine and K252a. Contrary to the poor inhibition of PKC mu by Gö 6983, this compound was found to suppress in vitro kinase activity of PKC isoenzymes from all three subgroups very effectively with IC50 values from 7 to 60 nM. Thus, Gö 6983 was able to differentiate between PKC mu and other PKC isoenzymes being useful for selective determination of PKC mu kinase activity in the presence of other PKC isoenzymes.

摘要

测试了多种抑制剂在体外和体内抑制蛋白激酶Cμ(PKCμ)激酶活性的潜力。在星形孢菌素衍生的、具有较高选择性的PKC抑制剂中,之前显示能优先抑制cPKC亚型的吲哚咔唑Gö 6976被证明是PKCμ的有效抑制剂,其IC50为20 nM,而双吲哚马来酰胺Gö 6983在抑制PKCμ激酶活性方面极其无效,其IC50高达20 μM,比前者高一千倍。PKCμ的其他强效抑制剂是特异性较差的抑制剂星形孢菌素和K252a。与Gö 6983对PKCμ的抑制作用较弱相反,该化合物被发现能非常有效地抑制来自所有三个亚组的PKC同工酶的体外激酶活性,IC50值在7至60 nM之间。因此,Gö 6983能够区分PKCμ和其他PKC同工酶,这对于在存在其他PKC同工酶的情况下选择性测定PKCμ激酶活性很有用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验